New energy cars are the fastest-growing segment so far. Some 78,000 such vehicles were sold in September, a 79 percent surge year-on-year and a nine-month high. Of them, electric cars are growing the fastest, with sales surging 83.4 percent to 64,000 in September.
Net profit for the July-September period surged by 51.6 percent year-on-year to around 1.84 billion yuan (about 4 million) while revenue grew by about 34 percent to 38.46 billion yuan, the company said in its financial report filed with the Shenzhen Stock Exchange.
Nelson Wang, executive director of CICC Research, said companies at the receiving end of the oil price drop are poised to benefit the most, including refiners, which are expected to gain over the medium or long term, although they might also get hurt alongside their upstream peers due to inventory losses.
New arrests have been made for offenses in protests over the last two months. Tse Chun-chung, chief superintendent of police public relations branch, said eight males were detained Wednesday, with seven of them involved in the besiegement of the Hong Kong Legislative Council, Police headquarters, or Hong Kong International Airport.
Nepal has already permitted International Finance Corporation (IFC), a private sector financing wing of the World Bank and Asian Development Bank (ADB) to issue Nepali Rupee bonds, but they are yet to issue such bonds.
Nearly 70 percent of China's listed firms posted higher net profits in the first half of the year (H1) amid the country's stable economic growth. [Photo/IC]
丽江问人流时间问题
Netflix, meanwhile, also announced today that it will increase its subscription plans by or this quarter. The company posted a Q1 income?of million and now has 12.68 million subscribers worldwide, up more than 5?million from this time last year.
New York City Mayor Bill de Blasio said Monday that the city may meet the thresholds set by the state to reopen in the first half of June.
Nation has reached 'world-class level' in some research areas, scientist reports
Nevada is one of several states trying to stop the rush for the drugs that they say has depleted supply for people who need them for established uses, including rheumatoid arthritis and lupus.